Atlas Trials

Feasibility of Combined Genomics/Transcriptomics for Patients With Lymphoma

Clinical trial NCT05464823 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT05464823
Sponsor
M.D. Anderson Cancer Center
Status
ACTIVE_NOT_RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Lymphoma
Start date
2022-07-07
Primary completion
2027-05-12
Enrollment
111

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.